MAM
Aamir Khan announced as PhonePe brand ambassador
MUMBAI: PhonePe, India’s fastest growing payments platform, today announced Bollywood superstar Aamir Khan as the face of its brand. PhonePe is also an official co-presenting sponsor for the television broadcast of VIVO IPL 2019 and will be launching a series of new TV ads featuring Aamir Khan during this season. Khan's presence in the TV ads and his mass appeal as a national icon will help PhonePe create awareness about the benefits of digital payments for users across India.
Commenting on the announcement PhonePe CEO and founder Sameer Nigam said, “Aamir Khan is among the world’s biggest superstars today. He is a highly renowned actor who is known for doing path-breaking work in his industry. In his personal capacity too, Aamir has been instrumental in creating awareness about many important social issues in India. His name is synonymous with sincerity, hard work, and dedication to his craft. These are values that are completely in sync with PhonePe’s ethos of trust, security, and reliability, therefore we felt that Aamir is the perfect brand ambassador for our company as we look to introduce Digital Payments to a billion Indians.”
“We are also very excited to be part of VIVO IPL 2019. Cricket is the most popular sport in the country and VIVO IPL is the biggest sporting event of the year. Thus, we feel it is a great platform for us to launch our new brand campaign with Aamir and create awareness about the PhonePe platform,” he added.
“PhonePe stands for innovation and trust and has been instrumental in simplifying digital payments for millions of Indians in a very short span of time. I have closely been following PhonePe’s amazing journey and am delighted to be a part of their phenomenal growth trajectory,” said Khan.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
